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Differentiationays a key role in the homeostasis of the intestinal epithelium. Whereas its role in
the maintenance of the stem cell compartment has been clearly demonstrated, its role in the Paneth cell fate
remains unclear. We performed genetic studies to elucidate the functions of the Wnt/β-catenin pathway in
Paneth cell differentiation. We analysed mice with inducible gain-of-function mutations in the Wnt/β-
catenin pathway and mice with a hypomorphic β-catenin allele that have not been previously described. We
demonstrated that acute activation of Wnt/β-catenin signalling induces de novo speciﬁcation of Paneth cells
in both the small intestine and colon and that colon cancers resulting from Apc mutations expressed many
genes involved in Paneth cell differentiation. This suggests a key role for the Wnt/β-catenin pathway in
Paneth cell differentiation. We also showed that a slight decrease in β-catenin gene dosage induced a major
defect in Paneth cell differentiation, but only a modest effect on crypt morphogenesis. Overall, our ﬁndings
show that a high level of β-catenin activation is required to determine Paneth cell fate and that ﬁne tuning of
β-catenin signalling is critical for correct Paneth cell lineage.
© 2008 Elsevier Inc. All rights reserved.Introduction
Epithelial cell differentiation in the intestine involves a series of
distinct steps (Sancho et al., 2003). In the adult, intestinal epithelial
cells originate from stem cells (Barker and Clevers, 2007; Bjerknes and
Cheng, 2005). Stem cells give rise to progenitor cells, which are
ampliﬁed by constant division along the bottom two thirds of the
crypts. Cell-cycle arrest and differentiation occur when progenitors
reach the top third of the crypts. Four differentiated cell types are
produced in the small intestine and can be classiﬁed into two groups
according to their function: absorptive cells, called the enterocytes;
and secretory cells, which include the Paneth, goblet and enteroendo-
crine cells. Recent elegant studies based on lineage tracing unequi-
vocally identiﬁed the intestinal epithelial stem cells (Barker et al.,itut Cochin, Université Paris
logy Metabolism and Cancer
aris, France. Fax: +33 144 4124.
agnolo).
l rights reserved.2007). However, the mechanisms of lineage commitment remain
largely uncharacterized.
The intestinal epithelium is continuously renewed; therefore
production of all lineages is a continuous feature of the intestine.
Proliferation and differentiation in the intestine are tightly regulated
by a number of molecular pathways (Walters, 2005). One such
pathway crucial for intestinal cell homeostasis is the Wnt/β-catenin
signalling. Previous studies strongly suggest that the Wnt/β-catenin
pathway plays important roles in normal intestinal homeostasis and
in colorectal cancers (Gregorieff et al., 2005). Indeed, mutations in the
Wnt/β-catenin signalling, mostly involving the inactivation of the APC
gene, have been found in most sporadic colorectal cancers (Morin
et al., 1997). Increasing evidence demonstrates that the initiation of
tumourigenesis is linked to the activation of the Wnt/β-catenin
signalling in most colorectal cancers (Andreu et al., 2005; Sansom
et al., 2004). In the absence of functional APC, β-catenin accumulates
in the cytoplasm and translocates to the nucleus with Tcf/lef
transcription factors, activating transcription of the Wnt/β-catenin
target genes (Clevers, 2006).
The most established effects of Wnt/β-catenin signalling in the
intestine are those involved in cell proliferation, in particular by
289P. Andreu et al. / Developmental Biology 324 (2008) 288–296maintaining the proliferative state of the progenitors (Andreu et al.,
2005; Korinek et al., 1998; Kuhnert et al., 2004; Pinto et al., 2003;
Romagnolo et al., 1999; Sansom et al., 2004). However, Wnt/β-
catenin signalling in the adult intestine is not conﬁned to
proliferating immature cells, but is also active in fully differentiated
Paneth cells. This cell lineage has a number of unique features.
Other differentiated cells migrate along the crypt–villus axis leading
to their rapid elimination within between three and ﬁve days,
whereas Paneth cells reside at the bottom of the crypts, in the close
vicinity of the stem cells, for about 60 days (Barker et al., 2007). In
contrast to the other differentiated lineages, this lineage emerges
during the cytodifferentiation of the foetal small intestine endo-
derm and achieves its complete differentiation after birth, during
the crypt morphogenesis, by post-natal days 14 to 28 (Bry et al.,
1994). The Wnt/β-catenin signalling maintains the correct position-
ing of the Paneth cells by controlling expression of the genes
encoding Ephrin B2/B3 receptors and the Ephrin B1 ligand. In
addition, our own and other previous studies have implicate a key
role of Wnt/β-catenin signalling in Paneth cell differentiation;
however, its exact role in this process is still unclear (Andreu et
al., 2005; Fevr et al., 2007; Ireland et al., 2004; Korinek et al., 1998;
Pinto et al., 2003; van Es et al., 2005). Does it act on their
speciﬁcation or maturation or both? In this study, we addressed
these issues and determined the role of the Wnt/β-catenin
signalling in Paneth cell lineage using a genetic approach. To this
end, we used two conditional models carrying ﬂoxed Apc alleles
and a mutant gain-of-function β-catenin gene in combination with
a tamoxifen-inducible Cre recombinase produced speciﬁcally in the
intestine (Colnot et al., 2004; el Marjou et al., 2004; Harada et al.,
1999). We also took advantage of a hypomorphic β-catenin allele to
study the effect of reducing β-catenin gene dosage. We demon-
strated that β-catenin signalling is absolutely required for Paneth
cell differentiation, both for commitment and maturation of this cell
lineage. Reduction of β-catenin signalling using a hypomorphic β-
catenin allele resulted in a mild proliferative defect in the immature
compartment, but induced a strong defect in Paneth cell differ-
entiation. Overall, our ﬁndings revealed a direct role for β-catenin
signalling in Paneth cell lineage differentiation that is highly
sensitive to a threshold level of β-catenin.
Materials and methods
Animals and treatment
All experiments involving mice were carried out in accordance
with French government regulations. Mice were housed in
conventional conditions. The generation of Apc+/− and Apc−/−
mice was described previously (Andreu et al., 2005; Colnot et
al., 2004). To achieve stabilization of β-catenin expression in the
intestine we crossed the Catnblox(ex3)/lox(ex3)mice (Harada et al.,
1999) with the Vil-CreERT2 mice (el Marjou et al., 2004) and
obtained Vil-CreERT2Catnblox(ex3)/lox(ex3). Tamoxifen injection (Tam)
induces Cre-mediated deletion, creating CatnbΔex3/Δex3. Cre recom-
binase was activated by a single intraperitoneal injection of Tam
solution (1 mg) (ICN, France) in conditional gene-targeted mice.
All mice analysed are on C57BL/6 background. Mice aged from 3
to 6 months were killed at various times after Tam injection, and
intestines collected.
In situ hybridisation
Immediately after killing the mouse, the entire gastrointestinal
tract was removed, splayed open along its length, ﬁxed in 4% formol
and rolled up from the proximal to distal end to form a ‘Swiss roll’.
Slices 7 µm thick of the parafﬁn-embedded Swiss rolls were used for
in situ hybridisation. Partial cDNA sequences of Lyzs, Spink4 andCryptdin were ampliﬁed by RT–PCR and inserted into PGEMT.
Digoxigenin (DIG)-labelled RNA probes were prepared by in vitro
transcription with the Dig RNA labelling kit (Roche) using T7 or Sp6
RNA polymerases.
Sections were deparafﬁnised and treated with Triton 0.3×in PBS,
0.1 mg/ml Proteinase K in Tris/EDTA (100 mM/50 mM). Sections were
then washed in PBS, treated with 0.25% acetic acid containing 0.15 M
triethanolamine and prehybridised for one hour at 68 °C in
hybridisation buffer containing a salt solution (0.3 M NaCl, 10 mM
Tris, 50 mM NaH2PO4, 50 mM Na2HPO4, 50 mM EDTA), Denhardt's
solution, 10% Dextran sulphate and 0.1 mg/ml Yeast rRNA (Sigma).
Sections were incubated overnight at 68 °C in the prehybridisation
buffer containing 200 ng/ml of DIG-labelled RNA probe. Slides were
washed once for ﬁve minutes in 5×SSC at 68 °C, and for one hour at
68 °C in 0.2×SSC. Hybridised probe was detected using an anti-
digoxygenin antibody (Roche, 1/4000) and NBT/BCIP (Vector) as
substrate.
Histology
Sections (5 µm thick) of the parafﬁn-embedded Swiss roll were
treated with 3% hydrogen peroxide. Antigen was retrieved by treating
sectionswith citrate buffer at pH 6 in amicrowave pressure cooker (EZ
retriever, Biogenex). We used polyclonal primary antibodies directed
against ANG4 (provided by J. Gordon,Washington University School of
Medicine, Saint Louis, USA; 1/500), CRS1C-1, CRS4C-1, DEFCR-5, (all
provided by A Ouellette, University of California Irvine, USA; 1/200),
lysozyme (Dako; 1/500) and Ki-67 (Novocastra; 1/300). The number of
crypts and Paneth cells were counted in 10 to 12 jejunum longitudinal
sections stained with Ki-67 or lysozyme staining, respectively
(100×objectives). Areas of lysozyme positive cells were estimated
using Image J software.
Electron microscopy
2-mm tissue pieces were ﬁxed in 2.5% glutaraldehyde in 0.1 M
cacodylate buffer and kept at 4 °C. After several thorough washes
in 0.1 M cacodylate buffer, the blocks were postﬁxed in 1% osmium
tetroxide for 1H30 and washed in water prior staining with uranyl
acetate for 30 min. After inclusion in epoxy resin, 300 to 400 nm
semithin sections were ﬁrst realized to control the good orientation
of the samples, then 80 to 90 nm sections were cut on a Reichert
Ultracut E ultramicrotome. The ultrathin sections were transferred
onto 150-mesh copper grids before staining with uranyl acetate
and. lead citrate. The sections were then viewed with a H600
Hitachi transmission electron microscope at 75 kV accelerating
voltage.
Collection of patient samples
Five primary colorectal adenomas and corresponding normal
tissue were collected at the Hotel-Dieu and Cochin Hospitals (Paris,
France). Nineteen primary colorectal cancers and adjacent tissue were
collected at the Laennec Hospital (Paris, France).
RNA analyses
Extraction of total RNA and northern blots were performed as
previously described (Ovejero et al., 2004). For RT–PCR, 2 µg of total
RNA was reverse-transcribed using Superscript II RNaseH RT (Invitro-
gen) and random hexamers. Real-time quantitative RT–PCR was
carried out with a Light Cycler instrument using the Light Cycler-
fastStart DNA Master SYBR Green I Kit (Roche Diagnostics). Quanti-
ﬁcation was carried out in duplicate and results were expressed
relative to 18s rRNA. PCR primer sequences are available in supple-
mental materials and methods.
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Acute activation of Wnt/β-catenin signalling by Apc loss induces de novo
differentiation of Paneth cells both in the small and large intestine
In a previous study we focused on the role of Apc to describe
broadly the immediate consequences of Apc loss on intestinal
homeostasis (Andreu et al., 2005). For this study, we generated a
conditional mutant mouse model for Apc deletion that produces a
Cre recombinase speciﬁcally in the intestinal epithelial cells,
inducible by tamoxifen (Tam) (Apclox/loxVilCreERT2). Tam-induced
Apc deletion increased cell proliferation causing crypt expansion,
increased apoptosis and impaired cell migration. We also observed
the induction of cryptdin and lysozyme mRNA production three days
after Tam injection. Cryptdin and lysozyme are both markers of
Paneth cells. Thus, Apc loss may be involved in Paneth cell
differentiation. Apc mutant mice (named Apc−/−) became ill three
days after Tam injection and had to be euthanized between days ﬁve
and six. We ﬁrstly examined the status of Paneth cells by histological
analysis. Paneth cells are easily identiﬁed by their typical eosinophilic
secretory granules (Fig. 1A). We observed cells with characteristic
cytosolic apical granules typical of Paneth cells throughout the
expanded crypt compartment in Apc−/− six days after Tam injection
(Fig. 1B). The granules were large, demonstrating complete andFig. 1. Apc loss promotes Paneth cell differentiation in the small and large intestine. Repre
control mice (A, E) and from Apc−/− six days after Apc ablation (B, F). Abnormal, mislocalised
localisation of Paneth cells in Apc−/−mice at day six after Apc ablation in both the small (D) an
high magniﬁcations. (I, J) Ultrastructural evaluation of Paneth cells in Apc−/− mice. (I) Secreto
highly developed and dilated endoplasmic reticulum (asterisks) which underline active matu
electron dense secretory granules (SG) and immature Paneth cell showing electron lucent
positive per crypt unit on day six (d6) in Apc−/− (black bars) and control mice (white bar) (n=3
represent standard errors.terminal differentiation in the Paneth cell lineage (Bry et al., 1994).
Ultrastructural analyses conﬁrmed the presence of mature Paneth
cells all along the crypt–villus axis in Apc mutant mice (Figs. 1I and J).
In these cells, secretory granules showed the characteristic bipartite
structure with a large round central core of high electron density and
a peripheral halo of lower density. In contrast the immature Paneth
cells present secretory granules within an eccentrically located dense
core surrounded by a ﬁnely granular homogeneous material.
Lysozyme immunostaining in Apc−/− at day six was consistent with
the appearance of Paneth cells throughout the crypt of the small
intestine (Figs. 1C and D). We distinguished between potential
speciﬁcation and/or mislocalisation of the Paneth cell lineage
following Apc loss, by counting lysozyme-positive cells and thus
determining the number of Paneth cells six days following Tam
injection. The percentage of lysozyme-positive cells per crypt unit
was estimated as 27% in Apc mutant mice compared to 9% in control
mice (Fig. 1K). These ﬁndings suggest that loss of Apc expression
promotes Paneth cell speciﬁcation. Moreover, although there are no
Paneth cells in the normal mouse colon, analyses of the colon from
Apc−/− mice revealed the appearance of numerous morphologically
recognisable Paneth cells at day six after Tam injection (Figs. 1E and
F). These cells contained typical secretory granules indicating that
they were fully mature Paneth cells and were positive for the
lysozyme marker (Figs. 1G and 1H).sentative haematoxylin/eosin-stained sections of jejunum (A, B) and colon (E, F) from
Paneth cells are indicated by arrowheads. Lysozyme (LYZ) staining conﬁrms the ectopic
d the large intestine (H), not observed in control mice (C, G). Scale bars, 50 µm. Inset are
ry granules within Paneth cells at the base of the crypt. Note that Paneth cells contain a
re Paneth cell. (J) Presence of many Paneth cells in the villi. Mature Paneth cells showing
materials (arrows). Scale bars, 2 µm. (K) Means indicate the percentage of lysozyme-
animals per genotype). P values were calculated by Student's t test. ⁎⁎pb0.01. Error bars
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on Paneth cell differentiation by analysing the expression of genes
speciﬁc to the other intestinal epithelial lineages using quantitative
real-time RT–PCR. Apc loss leads to an ampliﬁcation of the immature
progenitor cells and is associated with a decrease expression in many
differentiatedmarkers such as enterocyte, goblet and enteroendocrine
(Sup. Table 1). Then consistent with our previous observations, this
analysis suggests that the Paneth cell lineage is the only lineage
committed following Apc loss (Andreu et al., 2005).
Thus, we demonstrate that Apc loss, leading to a sustained strong
activation of the β-catenin signalling, is sufﬁcient to rapidly induce de
novo speciﬁcation of Paneth cells both in the small and large
intestines.Fig. 2. Paneth cell markermRNA levels over time following Apc loss. (A) Graphs show quantita
control mice and black bars represent Apc−/−mice at various times after Tam injection (day th
by Student's t test, ⁎pb0.05; ⁎⁎pb0.01. Error bars represent standard errors. (B) Jejunum of co
(A, B), CRS4C-1 (C, D), DEFCR-5 (E, F), ANG4 (G, H) immunohistochemical stainings. SPINK4Analysis of the Paneth cell genetic proﬁle following loss of Apc
To assess the differentiation state of the Paneth cell lineage
following Apc loss, we examined the expression proﬁle, by quantita-
tive real-time RT–PCR, of eight speciﬁc Paneth cell markers in Apc−/−
mice following Tam injection (Fig. 2A). As expected, the β-catenin
target genes, Ephrin B3 (EphB3), Matrix metalloproteinase 7 (Mmp7),
Defensin-related cryptdin peptide (Defcr-rs1), and Lysozyme (Lyzs),
were rapidly induced after Apc deletion (Andreu et al., 2005; Batlle et
al., 2002; Crawford et al., 1999; van Es et al., 2005) (Fig. 2A). Likewise,
Peptidoglycan recognition protein 1 (Pglyrp1), Serine peptidase inhibitor,
Kazal type 4 (Spink4), Angiogenin 4 (Ang4) and Phospholipase A2, group
IIA (Pla2g2a), never previously reported to be regulated by β-catenintive real-time RT–PCR analysis of Paneth cell markermRNA levels. White bars represent
ree (d3), day four (d4), day six (d6) (n=3 animals per genotype). P values were calculated
ntrol mice (A, C, E, G, I) and Apc−/−mice (B, D, F, H, J) six days after Tam injection. CRS1C-1
(I, J) RNA in situ hybridisation. Scale bars, 50 µm.
Fig. 3. Paneth cell-speciﬁc genes are induced during progression of murine and human
colon tumourigenesis. In situ hybridisation of LYZ (A, B) in colonic adenomas fromApc+/−
mice. Non tumour (NT) and tumour-derived tissue samples (T) are delineated by a
dashed line. Scale bars: A, 150 µm; B, 50 µm. (C) Analysis of Paneth cell marker mRNA
levels in human colonic carcinogenesis. Percentage and number of human adenomas
(n=5) and human adenocarcinomas (n=19) with at least a two-fold difference when
compared with normal control tissue, using quantitative real-time RT–PCR analysis.
Fig. 4. β-catenin activation controls Paneth cell differentiation. (A) Representative
haematoxylin/eosin-stained sections (A, B) and LYZ immunostaining (C, D) of jejunum
from control mice (A, C) and β-catenin-targeted CatnbΔex3/Δex3 mice (B, D) six days after
Tam injection. Mislocalised Paneth cells aberrantly distributed along the crypt are
indicated by arrowheads. Inset is a high magniﬁcation of (B). (E) Analysis of Paneth cell
marker mRNA levels by quantitative real-time RT–PCR in control mice (white bars) and
CatnbΔex3/Δex3 mice (black bars) six days after Tam injection. n=3 animals per genotype.
P values were calculated by Student's t test, ⁎pb0.05; ⁎⁎pb0.01. Error bars represent
standard errors.
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tested were up-regulated; we detected increased levels of cryptdin
family proteins (CRS1C-1, CRS4C-1, DEFCR-5), and ANG4 by immu-
nostaining, and SPINK4, by in situ hybridisation (Fig. 2B). Thus, Apc
loss rapidly induced gene expression, resembling a proﬁle typical of
Paneth cells.
Aberrant Apc loss frequently occurs in colon carcinogenesis. We
thus analysed the presence of Paneth cell markers in intestinal
tumours from Apc+/− mice, a mouse model of familial adenomatous
polyposis carrying an Apc germline mutation. All Paneth cell markers
tested by quantitative real-time RT–PCR, except ANG4 and SPINK4,
were strongly induced in murine colonic adenomas (Sup. Fig. 1). In situ
hybridisation revealed that LYZS was present in dysplastic epithelial
cells of the adenoma (Figs. 3A, B). Analyses of human colon adenomas
and carcinomas conﬁrmed induction of these Paneth cell markers
(Fig. 3C and Sup. Fig. 2). However, all but HD6 (human ortholog of
cryptdin genes) were preferentially up-regulated in adenomas.
Altogether, our data demonstrate that Apc loss during colorectal
tumourigenesis leads to the de novo expression of the differentiated
Paneth cellular proﬁle.
β-catenin signalling activation per se induces de novo Paneth
cell speciﬁcation
Apc is a multidomain protein that contains binding sites for
numerous proteins and then can be deﬁned as a multifunctional
tumour suppressor gene (Aoki and Taketo, 2007; Nathke, 2004).
However, deregulation of β-catenin signalling appears to be the major
consequence of Apc loss in tumour initiation.We compared the effects
of Apc inactivation with those of a gain-of-function β-catenin
mutation on Paneth cell differentiation. The mouse β-catenin protein
is encoded by the Catnb gene. We achieved stabilization of β-catenin
expression by crossing a conditional β-catenin-targeted mouse strain,
Catnblox(ex3) (Harada et al., 1999), with transgenic mice, Vil-CreERT2 (el
Marjou et al., 2004) (Fig. 5A). Tam injection induces Cre-mediated
deletion to create CatnbΔex3/Δex3, a gain-of-function allele producing
constitutively activated β-catenin due to the absence of GSK3
phosphorylation sites (Fig. 5A). Morphological analysis of CatnbΔex3/Δex3
mice at day six revealed an expansion of the crypt compartment
associated with a strong induction of cell proliferation (Figs. 4A, B and
Sup. Fig. 3). Morphological analysis and LYZ immunostaining revealed
a net increase in the number of Paneth cells in the expanded crypt
(Figs. 4A–D). This was consistent within the higher mRNA levels inCatnbΔex3/Δex3 mice than in control mice observed for EphB, Pla2g2a,
Mmp7 and Lyzs (Fig. 4E). These observations were similar to those
described above for the Apc−/− mice (Andreu et al., 2005); thus, the
effects of Apc loss in the intestinal epithelium on cell proliferation and
Paneth cell differentiation can be mimicked by β-catenin activation.
These ﬁndings suggest that the effects of Apc loss are mediated by
Wnt/β-catenin signalling.
The β-catenin hypomorphic allele causes severe Paneth cell defects,
with graded effects on cell proliferation
Examination of the Catnblox(ex3)/lox(ex3) mice led to the discovery of
abnormal morphology of the intestinal epithelium present in some of
the mice in which cre-mediated recombination was not induced. The
Fig. 5. The Neo cassette causes a reduction of β-catenin levels in Catnblox(ex3)
homozygous mice. (A) Schematic representation of the β-catenin allele in
Catnblox(ex3)/lox(ex3) mice. Exons 2 to 4 are represented by white boxes. PGK-Neo
cassette (grey box) and lox P sequences (triangles) are indicated. The insertion of the
Neo cassette generates a β-catenin hypomorphic allele. After Tam injection, Cre
recombinase activity generates the CatnbΔex3/Δex3 allele. Exon 3 deletion encompasses
GSK3β phosphorylation sites and results in a β-catenin gain-of-function allele.
Northern blotting analysis (B) and quantiﬁcation (C) of β-catenin and α-actin mRNA
from Catnblox(ex3)/lox(ex3) and control mouse intestine and liver. P values were calculated
by Student's t test. ⁎⁎⁎pb0.01. Error bars represent standard errors.
Fig. 6. Reduced β-catenin levels disrupts crypt morphology. Haematoxylin/eosin (A, B)
and Ki-67 (C, D) staining revealed crypt-deﬁcient areas juxtaposing enlarged crypts in
Catnblox(ex3)/lox(ex3) mice with severe phenotypes (B, D), not observed in control mice (A,
C). Branching and enlarged crypts are indicated by arrows and arrowheads, respectively.
(E) Graphical representation of the number of crypts per µmderived from Catnblox(ex3)/lox(ex3)
mice (black bars, severe and mild phenotypes) and control mice (white bars) (n=4 for
control mice, n=3 for mild phenotype, n=7 for severe phenotype). P values were
calculated by Student's t test. ⁎⁎⁎⁎pb0.001. Error bars represent standard errors.
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resistance cassette (Neo), with the direction of transcription opposite
to that of Catnb. Our observations therefore suggest that Catnblox(ex3)
is a hypomorphic allele (Fig. 5A) (Harada et al., 1999). Previous studies
have shown that a Neo insertion within the coding region of an active
gene can result in the reduction of gene expression (Meyers et al.,
1998; Xu et al., 2001). We evaluated the expression level of β-catenin
mRNA by northern blot in Catnblox(ex3)/lox(ex3) mice. β-catenin mRNA
levels in the intestine of Catnblox(ex3)/lox(ex3) mice were about 75±9.8%
(pb0.01) those of wild-type intestine (100±3.9%) and 58±17%
(pb0.01) of wild-type liver (100±12.9%) (Figs. 5B and C). It has been
previously reported that the Neo cassette contains cryptic splice sites.
We examined β-catenin transcripts for splicing events between exons
1 and 7 using RT–PCR. However, we only observed the normal splicing
product and did not detect any aberrantly spliced mRNA. Sequence
analyses conﬁrmed that no aberrant mRNA was produced (data not
shown). Western immunoblot and immunohistochemistry revealed
similar β-catenin levels in homozygous mutant and wild-type mice,
probably reﬂecting a threshold detection limit (data not shown).
Histological examination revealed twopopulationsof Catnblox(ex3)/lox(ex3)
mice distinguished on the basis of crypt morphology. Eight of 14
Catnblox(ex3)/lox(ex3) mice (57%) had substantial defects in cryptal archi-
tecture with crypt-deﬁcient areas neighbouring crypts displayingdistortion, dilatation and branching without distinct cellular atypia
(Figs. 6A to D). These defects were associated with a substantially
lower number of crypts in Catnblox(ex3)/lox(ex3) mice than in control
mice (about 50±7.9% fewer crypts in Catnblox(ex3)/lox(ex3) mice,
pb0.001) (Fig. 6E, Catnblox(ex3)/lox(ex3), severe phenotype). The other
Catnblox(ex3)/lox(ex3) animals (six of 14) had a mild phenotype displaying
a tendency for fewer crypts than in control mice (26±9.4%, pb0.06)
(Fig. 6E, Catnblox(ex3)/lox(ex3), mild phenotype). Changes in crypt
morphology in the Catnblox(ex3)/lox(ex3) mice analysed varied along the
small intestine, with the most severe phenotypic defects in the
duodenum and the jejunum and gradually weaker defects thereafter
(data not shown).
Themost striking feature of the small intestine in Catnblox(ex3)/lox(ex3)
adult mice was the quasi total absence of cytosolic granules of Paneth
cells in remaining crypts observed in the severe phenotype (Fig. 7A
and B). Consequently, the bottom of the crypts was occupied by
proliferating cells, indicated by Ki-67 staining (Figs. 7C and D). The
Paneth cell defect was most pronounced in the duodenum and
jejunum. Consistent with this observation, LYZ, Cryptdin, ANG4 mRNA
and/or protein levels were signiﬁcantly reduced (Figs. 7E–I and Sup.
Fig. 4). Paneth cell number was analysed by counting lysozyme-
positive cells in the jejunum section. Mice with severe crypt defects
had a massive loss of Paneth cells, with signiﬁcantly fewer
LYZ-positive cells (87±6.8% fewer, pb0.001) than control mice.
Catnblox(ex3)/lox(ex3) mice with “mild” defects in crypt morphology
also had a substantial reduction in Paneth cell number, with 63±2.8%
(pb0.05) fewer cells than in control mice (Fig. 7J). The distinction
Fig. 7. Reduced β-catenin levels lead to signiﬁcant defects in Paneth cell differentiation. Haematoxylin/eosin staining revealed that Paneth cells are absent in the jejunum of
Catnblox(ex3)/lox(ex3) mice with a severe phenotype (B), but present in control mice (A). Ki-67 immunostaining in control (C) and Catnblox(ex3)/lox(ex3) mice with a severe phenotype
(D) indicates that Paneth cells are replaced by proliferative cells. Insets are high magniﬁcations. LYZ (E, F, G) and ANG4 (H, I) immunostaining conﬁrmed losses of Paneth cell in
Catnblox(ex3)/lox(ex3) (F, G, I), and normal distribution in control mice (E, H). Representative sections of LYZ immunostaining observed in Catnblox(ex3)/lox(ex3) mice classiﬁed as mild
phenotype (F), and severe phenotype (F); ANG4 immunostaining observed in Catnblox(ex3)/lox(ex3) mice with severe phenotype (I). Scale bars, 50 µm. (J) Quantiﬁcation of lysozyme-
positive cells in control (white bar) and Catnblox(ex3)/lox(ex3) mice (black bars) (n=4 for control mice, n=4 for mild phenotype, n=7 for severe phenotype). P values were calculated
by Student's t test. ⁎pb0.05, ⁎⁎⁎⁎pb0.001. Error bars represent standard errors.
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to be due at least in part to variable levels of β-catenin mRNA; indeed,
northern blot analyses suggested that there was a correlation between
the severity of the phenotype and β-catenin levels. β-Catenin mRNA
levels in animals developing a severe phenotype accounted for 63%
±32% (pb0.001) of those in wild-type (100±9%); β-catenin mRNA
levels in animals with a mild phenotype were 86±15% of control
levels, but this did not reach statistical signiﬁcance (pb0.07).
Altogether, these ﬁndings suggest that attenuation of β-catenin
signalling affects crypt cell proliferation and Paneth cell differentia-
tion. A slight reduction in β-catenin mRNA levels causes speciﬁc
abnormalities in the Paneth cell lineage, indicating that elevated β-
catenin levels are necessary for normal differentiation of the Paneth
cell lineage. These results also suggest that the Paneth cell defects are
independent of crypt deﬁciency since many morphologically normal
crypts had signiﬁcantly reduced numbers of Paneth cells.
Discussion
The initial hallmark of the intestinal activation of Wnt/β-catenin
signalling has been cell proliferation (Korinek et al., 1998). More
recently, many genetic studies have demonstrated thatWnt/β-catenin
signalling maintains the proliferation of crypt progenitor cells during
normal intestinal homeostasis, and that overexpression of Wnt/β-catenin signalling leads to abnormal cell proliferation, sufﬁcient to
initiate adenoma formation (Andreu et al., 2005; Fevr et al., 2007;
Kuhnert et al., 2004; Pinto et al., 2003; Sansom et al., 2004).
The role of Wnt/β-catenin signalling in intestinal cell differentia-
tion is less clear. In this study, we analysed Paneth cell lineage in
mutant mice in which the Wnt/β-catenin signalling is altered in a
graded fashion from overactivation that mimic the situation observed
in physiopathology during colorectal cancer, to a mild reduction, in
order to clarify its role in normal intestinal physiology. We
characterised the status of Paneth cells in two conditional mutant
mice with overactivation of β-catenin signalling: a conditional Apc-
null allele (Apclox/lox) and a conditional allele expressing a stabilised
β-catenin (Catnblox(ex3)/lox(ex3)). We showed that the Catnblox(ex3)
allele —precursor of the Cre-induced gain-of-function allele— is
hypomorphic. We demonstrated that overactivation of β-catenin
signalling in the mouse adult intestine is sufﬁcient for the
speciﬁcation and complete de novo differentiation of Paneth cells.
Accordingly, we showed that several Paneth cell markers are
expressed in mouse and human colorectal cancers associated with
aberrant activation of the Wnt pathway. These ﬁndings are consistent
with colonic Paneth cell metaplasia (PaM) previously observed by
pathologists in human colorectal cancers (Symonds, 1974; Wada et
al., 2005). In contrast to our study, a previous study suggested that
Wnt/β-catenin signalling is required for the maturation but not the
295P. Andreu et al. / Developmental Biology 324 (2008) 288–296speciﬁcation of the Paneth cell lineage; indeed, mice lacking the
Wnt-receptor Frizzled5 (Fz5) displayed only partial defects in Paneth
cell marker expression (MMP7 and cryptdin detected, but not LYZ)
(van Es et al., 2005). The difference between our study and that of
Van Es and colleagues probably reﬂects the fact that other Frizzled
family genes, Fz6 and Fz7 are expressed throughout the crypt base
(Gregorieff et al., 2005) and may thus partially compensate for the
loss of Fz5 and for some of the molecular consequences of β-catenin
signalling in the Paneth cell lineage.
In addition, we found that the differentiation of the Paneth cell
lineage in hypomorphic β-catenin mutant mice was disrupted.
Interestingly, the Paneth cell lineage was highly sensitive to changes
in β-catenin dosage: a mild reduction in β-catenin mRNA levels
severely disrupted development of the Paneth cell lineage, but effects
on intestinal cell proliferation were limited. Our ﬁndings are
consistent with previous studies suggesting that β-catenin signalling
is involved in intestinal cell differentiation in embryonic development.
Post-mitotic cells in villi are major sites of β-catenin activity, whereas
proliferating cells show no evidence of β-catenin signalling (Kim et al.,
2007). The role of β-catenin signalling in cell differentiation has been
described in many distinct cell types such as the hair follicle, bile duct,
cardiac cell lineages, osteoblasts, the pituitary gland and neural crest
cells (Decaens et al., 2008; Kwon et al., 2007; Lee et al., 2004; Lowry et
al., 2005; Olson et al., 2006; Rodda and McMahon, 2006). Our results
also highlight new ﬁndings regarding a distinct requirement of β-
catenin levels to assure crypt progenitor cell proliferation and Paneth
cell differentiation. This is consistent with previous reports indicating
that Paneth cells express a higher level of nuclear β-catenin other than
crypt cells (van Es et al., 2005). We suggest that Paneth cell
differentiation is highly sensitive to a threshold level of β-catenin
signalling and that proper development of the Paneth cell lineage
requires ﬁne tuning of β-catenin activation. The effect on cell
proliferation appears to be linked to a further reduction in β-catenin
levels. Thus, the graded effects of reduced β-catenin dosage on
proliferation and differentiation, observed in mice expressing the
hypomorphic β-catenin allele, may underlie concentration-dependent
cellular responses, highlighting the role of Wnt as a morphogen.
The molecular mechanisms underlying Wnt/β-catenin signalling-
mediated Paneth cell gene expression are not fully understood. Many
Paneth cell markers were rapidly induced in response to hyperactivation
ofWnt/β-catenin signalling in themouse intestine, althoughwith varying
kinetics. Thus, different Paneth cell markers appear to have distinct
responses toβ-catenin activation. Basedonour previous observations and
other studies, some genes appear to be directly regulated by the β-
catenin/Tcf transactivation complex (cryptdin, MMP7, EphB3), whereas
others may require transcriptional activation by a β-catenin-induced
transcription factor. Consistent with this, two recent reports demonstrate
that the transcription factor Sox9, a direct transcriptional target of the β-
catenin/Tcf4 complex, is needed for Paneth cell speciﬁcation (Bastide et al.,
2007; Mori-Akiyama et al., 2007). Both reports demonstrate that
conditional ablation of the Sox9 gene in the intestine leads to the absence
of Paneth cells. It is thus likely that Sox9 is involved in the molecular
mechanism underlying the role of the Wnt signalling in Paneth cell
speciﬁcation. Accordingly, we observed an increase in Sox9 levels in the
small intestine of mice with overactivation of β-catenin signalling (data
not shown). However, the molecular mechanisms underlying the role of
Sox9 in Paneth cell differentiation is unknown.
A particular feature of the β-catenin hypomorphic mouse pheno-
type is the juxtaposition of crypt-deﬁcient areas and hyperplastic
crypts. These ﬁndings are not in line with previous studies suggesting
that loss of β-catenin leads to complete ablation of the crypt cells
(Korinek et al., 1998; Kuhnert et al., 2004; Pinto et al., 2003). There are
several possible explanations for this. The presence of hyperplastic
crypts next to crypt-deﬁcient areas is highly reminiscent of repopula-
ting crypts following irradiation (Potten et al., 1990). The phenotype
observed in the β-catenin hypomorphic mouse intestine is variablealong the intestine which probably reﬂects a mosaic reduction in β-
catenin expression. It is possible that reduction of β-catenin below a
threshold level may not be tolerated, and induces a regenerative
response. Such a compensatory phenotype has been previously
observed in mice with partial conditional deletion of β-catenin and
c-myc in intestinal epithelial cells (Ireland et al., 2004; Muncan et al.,
2006). Another possibility is that the hyperplastic crypts are a
consequence in the absence of Paneth cells. We tested the hypothesis
that the hyperplasia results from inﬂammation caused by Paneth cell
deﬁciency. Indeed, given that Paneth cells secrete multiple antimicro-
bial peptides and protect the epithelium against luminal bacteria
(Wehkamp and Stange, 2006), the absence of Paneth cells could lead to
a larger bacterial load and inﬂammatory cell inﬁltration, leading to
reactive hyperplasia. However, CD45 immunostaining revealed similar
inﬂammatory cell inﬁltration for Catnblox(ex3)/lox(ex3) and control mice
(data not shown). Furthermore, we observed that the bottom of the
crypts, normally occupiedbyPaneth cells,was replaced byproliferating
cells in hypomorphic β-catenin mice. However, similar observation
were reported for othermousemodels displaying a reduction in Paneth
cell number: for example, in transgenic mice expressing a toxin gene
under the cryptdin-2 promoter and inmutantmicewith ablation of the
gene encoding Gﬁ-1, a secretory cell lineage determinant (Garabedian
et al.,1997; Shroyer et al., 2005). However, hyperplastic crypts have not
been reported for any of these models. Thus, to date, there is no direct
evidence showing that the hyperplastic crypts observed in β-catenin
hypomorphic mice are linked to the deletion of Paneth cells.
In conclusion, our genetic study demonstrates that on top of its well
established role in intestinal cell proliferation, β-catenin signalling
regulates Paneth cell fate. We also demonstrated that reduction in β-
catenin levels can induce distinct cellular responses, probably linked to
variable β-catenin gene dosage. Therefore, the level ofβ-catenin activity
must be tightly controlled in vivo to “ﬁne tune” β-catenin signalling for
the speciﬁcation of Paneth cells and the regulation of cell proliferation.
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